The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Increase in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 15th total of 7,400 shares. Based on an average trading volume of 28,300 shares, the short-interest ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 2.5 %

CGABL stock opened at $18.44 on Thursday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12 month low of $17.48 and a 12 month high of $20.85. The firm’s fifty day simple moving average is $18.72 and its 200-day simple moving average is $19.14.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st will be given a $0.2891 dividend. This represents a $1.16 annualized dividend and a yield of 6.27%. The ex-dividend date is Friday, January 31st. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.